Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.

× No keyword cloud information.

8 in total

Review 1. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors: J M Henwood; R N Brogden
Journal: Drugs Date: 1990-03 Impact factor: 9.546

Review 2. VP16-213 (etoposide). A critical review of its activity.

Authors: F Cavalli
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 3. Oral etoposide in germ cell tumours.

Authors: S Saxman
Journal: Drugs Date: 1999 Impact factor: 9.546

Review 4. The podophyllotoxin derivatives VP16-213 and VM26.

Authors: B F Issell
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

5. VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.

Authors: L H Einhorn
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

Review 6. Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies.

Authors: Gino In; Tanya Dorff
Journal: Urol Clin North Am Date: 2015-08 Impact factor: 2.766

7. Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine (BEPV).

Authors: B A Price; N H Peters
Journal: J R Soc Med Date: 1992-11 Impact factor: 18.000

8. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).

Authors: M J Peckham; A Barrett; K H Liew; A Horwich; B Robinson; H J Dobbs; T J McElwain; W F Hendry
Journal: Br J Cancer Date: 1983-05 Impact factor: 7.640

8 in total